相似文献
1
Binding of thromboxane A2/prostaglandin H2 agonists to human platelets.
Br J Pharmacol. 1987 May;91(1):223-7. doi: 10.1111/j.1476-5381.1987.tb09002.x.
2
Decrease in agonist affinity for human platelet thromboxane A2/prostaglandin H2 receptors induced by a platelet-derived supernatant.
Biochem Pharmacol. 1987 Jun 15;36(12):1913-7. doi: 10.1016/0006-2952(87)90488-6.
3
Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets.
J Pharmacol Exp Ther. 1985 Dec;235(3):729-34.
4
Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to guinea-pig platelets.
Eur J Pharmacol. 1986 Nov 12;131(1):49-54. doi: 10.1016/0014-2999(86)90514-5.
5
Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors.
J Pharmacol Exp Ther. 1985 May;233(2):418-24.
6
Binding of an 125I-labeled thromboxane A2/prostaglandin H2 receptor antagonist to washed canine platelets.
Mol Pharmacol. 1985 Aug;28(2):163-9.
7
Photoaffinity receptor antagonist for human platelet thromboxane A2/prostaglandin H2 receptors.
Biochem Pharmacol. 1990 Oct 1;40(7):1457-61. doi: 10.1016/0006-2952(90)90440-v.
8
The affinities of prostaglandin H2 and thromboxane A2 for their receptor are similar in washed human platelets.
Biochem Biophys Res Commun. 1988 Dec 15;157(2):733-9. doi: 10.1016/s0006-291x(88)80311-5.
9
Differential effect of pH on thromboxane A2/prostaglandin H2 receptor agonist and antagonist binding in human platelets.
J Biol Chem. 1991 Jul 25;266(21):13752-8.
10
Subcellular localization of a thromboxane A2/prostaglandin H2 receptor antagonist binding site in human platelets.
Biochem Pharmacol. 1988 Feb 15;37(4):647-54. doi: 10.1016/0006-2952(88)90138-4.
引用本文的文献
1
Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding.
Psychopharmacology (Berl). 1996 Mar;124(1-2):57-73. doi: 10.1007/BF02245606.
2
Difluorothromboxane A2 and stereoisomers: stable derivatives of thromboxane A2 with differential effects on platelets and blood vessels.
Proc Natl Acad Sci U S A. 1989 Jul;86(14):5600-4. doi: 10.1073/pnas.86.14.5600.
3
Inhibitory effect of a selective thromboxane A2 receptor antagonist, EP 092, on platelet aggregation in whole blood ex vivo and in vivo.
Br J Pharmacol. 1989 Feb;96(2):395-405. doi: 10.1111/j.1476-5381.1989.tb11830.x.
本文引用的文献
1
Aggregation of blood platelets by adenosine diphosphate and its reversal.
Nature. 1962 Jun 9;194:927-9. doi: 10.1038/194927b0.
2
Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations.
Br J Pharmacol. 1981 Jul;73(3):773-8. doi: 10.1111/j.1476-5381.1981.tb16814.x.
3
Stimulation of platelet protein phosphorylation by arachidonic acid and endoperoxide analogs.
Prostaglandins. 1981 Jul;22(1):81-94. doi: 10.1016/0090-6980(81)90055-1.
4
Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin.
Proc Natl Acad Sci U S A. 1983 Sep;80(17):5320-4. doi: 10.1073/pnas.80.17.5320.
5
6
Ligand binding to thromboxane receptors on human platelets: correlation with biological activity.
Br J Pharmacol. 1983 Aug;79(4):953-64. doi: 10.1111/j.1476-5381.1983.tb10541.x.
7
Influence of sodium on the alpha 2-adrenergic receptor system of human platelets. Role for intraplatelet sodium in receptor binding.
J Biol Chem. 1983 Mar 25;258(6):3913-9.
8
9
Platelet aggregation and exposure of fibrinogen receptors by prostaglandin endoperoxide analogues.
Blood. 1983 Jan;61(1):41-9.
10
Specific binding of the thromboxane A2 antagonist 13-azaprostanoic acid to human platelet membranes.
Biochim Biophys Acta. 1983 Feb;728(2):171-8. doi: 10.1016/0005-2736(83)90468-6.
Zotero 插件